Although previous studies showed that NK cells are essential anti-tumor immune cells that can be activated by IL-12 or IL-12/IL-7 (16, 18), the NK cells were found to be lower in the TME and were slightly downregulated by cytokine mRNA treatment in our study. This evidence concerns the gene IL7 and neoplasm.